Salomon & Ludwin’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Salomon & Ludwin's PCRX Position: Q3 2026 in Review
Salomon & Ludwin held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 335 shares worth $8.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1368.
Salomon & Ludwin first reported a position in PCRX in Q3 2025 and has held it in 5 quarters since. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Salomon & Ludwin held 335 shares of Pacira BioSciences worth $8.39K as of Q3 2026.
- Salomon & Ludwin left its Pacira BioSciences share count unchanged in Q3 2026.
- Pacira BioSciences made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #1368 holding.
- Salomon & Ludwin first reported a position in Pacira BioSciences in Q3 2025 and has held it in 5 quarters since.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.